NCT05769699Recruiting
Serum Biomarkers in Parkinson's Disease at Different Stages
Source: ClinicalTrials.gov · Last updated 15 Mar 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
* Determine clinical characteristics of parkinsonian patients in various stages of disease; * Measure peripheral neurodegeneration, synaptic, and inflammation biomarkers in a population of parkinsonian patients at various stages of disease. * Measure vesicular neurodegeneration, synaptic and inflammation biomarkers
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 28 Feb 2023
- Start date
- Feb 2022
- Primary completion date
- Dec 2023
- Lead sponsor
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS
- Diseases
- Parkinson disease
- NCT number
- NCT05769699
What you commit to
- Study type: Interventional
- Planned participants: 200
- From Feb 2022 to the primary completion date, Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Inflammatory or autoimmune diseases
Other
- Women pregnant
Who the study is looking for
- Patients diagnosed with idiopathic PD according to Movement Disorders Society (MDS) criteria;
- Age: 18-80 years;
- Signature of informed consent to participate in this study
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Flavia Torlizzi Coordinator of this site? Confirm its status | Roma | Italy | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.